BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2784944)

  • 1. Release of NO and EDRF from cultured bovine aortic endothelial cells.
    Myers PR; Guerra R; Harrison DG
    Am J Physiol; 1989 Apr; 256(4 Pt 2):H1030-7. PubMed ID: 2784944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide.
    Myers PR; Minor RL; Guerra R; Bates JN; Harrison DG
    Nature; 1990 May; 345(6271):161-3. PubMed ID: 2110626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial cyclic GMP and cyclic AMP do not regulate the release of endothelium-derived relaxing factor/nitric oxide from bovine aortic endothelial cells.
    Kuhn M; Otten A; Frölich JC; Förstermann U
    J Pharmacol Exp Ther; 1991 Feb; 256(2):677-82. PubMed ID: 1847208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EDRF: nitrosylated compound or authentic nitric oxide.
    Bates JN; Harrison DG; Myers PR; Minor RL
    Basic Res Cardiol; 1991; 86 Suppl 2():17-26. PubMed ID: 1953608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EDRF and nitric oxide production in cultured endothelial cells: direct inhibition by E. coli endotoxin.
    Myers PR; Wright TF; Tanner MA; Adams HR
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H710-8. PubMed ID: 1558180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelium-derived relaxing factor released from cultured cells: differentiation from nitric oxide.
    Dusting GJ; Read MA; Stewart AG
    Clin Exp Pharmacol Physiol; 1988 Feb; 15(2):83-92. PubMed ID: 3271606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells.
    Gryglewski RJ; Moncada S; Palmer RM
    Br J Pharmacol; 1986 Apr; 87(4):685-94. PubMed ID: 3085757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of native LDL and oxidized LDL on EDRF bioactivity and nitric oxide production in vascular endothelium.
    Myers PR; Wright TF; Tanner MA; Ostlund RE
    J Lab Clin Med; 1994 Nov; 124(5):672-83. PubMed ID: 7964125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does halothane interfere with the release, action, or stability of endothelium-derived relaxing factor/nitric oxide?
    Blaise G; To Q; Parent M; Lagarde B; Asenjo F; Sauvé R
    Anesthesiology; 1994 Feb; 80(2):417-26. PubMed ID: 8311324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does EDRF/NO regulate its own release by increasing endothelial cyclic GMP?
    Kuhn M; Förstermann U
    Basic Res Cardiol; 1991; 86 Suppl 2():27-35. PubMed ID: 1659373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelium-derived relaxing factor is a selective relaxant of vascular smooth muscle.
    Shikano K; Berkowitz BA
    J Pharmacol Exp Ther; 1987 Oct; 243(1):55-60. PubMed ID: 3499504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Close correlation between cytoplasmic Ca++ levels and release of an endothelium-derived relaxing factor from cultured endothelial cells.
    Korenaga R; Ando J; Ohtsuka A; Sakuma I; Yang W; Toyo-oka T; Kamiya A
    Cell Struct Funct; 1993 Apr; 18(2):95-104. PubMed ID: 8364982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Release of endothelium-derived relaxing factor (EDRF) from cultured vascular endothelial cells depends on extra- and intracellular Ca2+ concentrations].
    Korenaga R
    Hokkaido Igaku Zasshi; 1993 Sep; 68(5):744-54. PubMed ID: 8225180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelium-derived relaxing factor (EDRF) from cultured and fresh endothelial cells.
    Gryglewski RJ; Trybulec M; Radziszewski W; Swierkosz T; Dudek R; Zembowicz A
    Biomed Biochim Acta; 1988; 47(10-11):S61-6. PubMed ID: 2470361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet inhibition by endothelium-derived relaxing factor from the rabbit perfused aorta.
    Bult H; Fret HR; Van den Bossche RM; Herman AG
    Br J Pharmacol; 1988 Dec; 95(4):1308-14. PubMed ID: 3064856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1987 Nov; 92(3):639-46. PubMed ID: 3322462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of bovine endothelial thromboxane receptors triggers release of prostacyclin but not EDRF.
    Clesham G; Parsaee H; Joseph S; McEwan JR; MacDermot J
    Cardiovasc Res; 1992 May; 26(5):513-7. PubMed ID: 1446322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins.
    Chin JH; Azhar S; Hoffman BB
    J Clin Invest; 1992 Jan; 89(1):10-8. PubMed ID: 1309534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelium-derived relaxing factor release associated with increased endothelial cell inositol trisphosphate and intracellular calcium.
    Loeb AL; Izzo NJ; Johnson RM; Garrison JC; Peach MJ
    Am J Cardiol; 1988 Oct; 62(11):36G-40G. PubMed ID: 3263034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cells have a particulate enzyme system responsible for EDRF formation: measurement by vascular relaxation.
    Mitchell JA; Förstermann U; Warner TD; Pollock JS; Schmidt HH; Heller M; Murad F
    Biochem Biophys Res Commun; 1991 May; 176(3):1417-23. PubMed ID: 1710114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.